Belongs to

• Solid Tumor Oncology Division

Types of Work

["2024"]

[[["Journal Articles",412],["Meeting Abstracts",361],["Book Sections",21],["Reviews",19],["Editorials",7],["Guidelines",7],["Research Letters",6],["Correspondences",3],["Book Wholes",1],["Conference Papers",1],["Miscellaneous",1]]]

[839]

Popular keywords

• adult
• aged
• article
• cisplatin
• female
• human
• humans
• male
• middle aged
• priority journal

Recent Works

1. FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancers

   Meeting Abstract

   Schreck, K. C.; De La Fuente, M. I.; Rine, J.; Kline, I.; Shephard, S. P.; Ahnert, J. R.; Sherman, E. J.; Yaeger, R.
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save
2. Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma

   Journal Article

   Xu, B.; Baine, M. K.; Jungbluth, A.; Alabkaa, A.; Serrette, R.; Roy, D.; Rudin, C. M.; Ho, A. L.; Sherman, E.; Dogan, S.; more...
   Journal of Clinical Endocrinology and Metabolism (2025)

   Fulltext@MSK | Save
3. Phase II (Alliance A091802) randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma

   Journal Article

   Zandberg, D. P.; Allred, J. B.; Rosenberg, A. J.; Kaczmar, J. M.; Swiecicki, P.; Julian, R. A.; Poklepovic, A. S.; Bauman, J. R.; Phan, M. D.; Saba, N. F.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save